Navigation Links
Science Stacks Up for Flavonoids for Heart Health

A diet rich in flavonoids, compounds in fruit, vegetables, coffee, tea and chocolate, could slash the risk associated to cardiovascular disease//, says a joint Norwegian-US study.

The prospective cohort study of 34,489 postmenopausal women, published in the current issue of the American Journal of Clinical Nutrition, reports that high dietary intake of several classes of flavonoids can reduced the risk of mortality from cardiovascular disease (CVD), coronary heart disease (CHD) and stroke by between 10 and 22 per cent.

"This prospective study of postmenopausal women, with 16 years of follow-up, is, to our knowledge, the first study that has reported on total flavonoids and on seven subclasses of flavonoids," wrote lead author Pamela Mink from Washington-based Exponent Inc.

Flavonoids have been receiving interest with a mounting body of science, including epidemiological and laboratory-based, continuing to report the cancer-fighting potential of a number of different flavonoids, such as isoflavones, anthocyanidins and flavonols.

According to Business Insights, the market potential for flavonoids in the dietetic and nutritional supplement market is in excess of €670m ($862m) for 2007, with annual increases of 12 per cent.

The new study used a 127-item food frequency questionnaire to collect dietary information on 34,489 postmenopausal women (average age 62 at baseline, average BMI 27 kg per sq. m). The researchers used the new US Department of Agriculture databases of food flavonoid content to calculated flavonoid intakes.

After 16 years of follow-up, Mink and her co-workers found that 7091 participants had died, including 2316 from combined CVD, 1329 from CHD, and 469 from stroke.

After adjusting for potentially confounding factors such as age, energy intake, smoking, and physical activity, and dividing flavonoid intakes into five intake groups (quintiles) the researchers report that
'"/>




Page: 1 2 3

Related medicine news :

1. Science of swooning
2. The Science of Solar Eclipse
3. The Unpredictable Face Of Science
4. Science backs the importance of vegetables in diet
5. Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function
6. East And West Meet Under The Aegis of NY Academy Of Sciences
7. Getting Basic Science to Work For Medicine
8. Sleep Science awakens from deep slumber!
9. Arab World Wakes Up To the Call of Science
10. New Technique For Science Experiments
11. Computerized Patient Used to Teach Science to Medical Students
Post Your Comments:
(Date:9/5/2008)...odels are enhanced by taking into account risk fac... according to research teams led by epidemiologist... Center in two complementary papers appearing in t.... , In the first study to focus on African-Ameri...creased exposure to certain risks. Based upon thes...
(Date:9/4/2008)...e Medicare Advantage (MA) plans will be paid an av...red to what the same enrollee would have cost in t...ccording to a new report from The Commonwealth Fun...dated by the Medicare Improvements for Patients an... effect beginning in 2010 had been fully in place...
(Date:9/4/2008)...pancreatic tumors , , THURSDAY, Sept. 4 ...coveries involving genetic mutations of two deadly...reatic cancer -- may lead to new treatments and ev...present the most complete genetic analysis to date...map of these deadly cancers," Kenneth Kinzler, a p...
(Date:9/4/2008)...RNewswire/ -- Martin Schiff, M.D.,is an illustriou...weight,control and weight loss. His career is deta...he West," "Who,s Who in America," "Who,s Who in,th...and other honor rolls., Dr. Schiff recently retir...ate, misleading theories and notions concerning we...
Breaking Medicine News(10 mins):Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:Genetic Mutations Linked to Deadly Cancers 2Health News:Genetic Mutations Linked to Deadly Cancers 3Health News:Genetic Mutations Linked to Deadly Cancers 4Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2
...alyzing the neuronal receptor activity in the post...ia, researchers at the University of Pennsylvania ...ists at the City University of New York, have foun...h level of erbB4 receptor activity and reduced NMD...
...a of subjecting drug addicts to shock therapy as a... debates and controversies. Now, the Scottish Exec...rapy //. Shock therapy technically labeled as Neu...with the use of self-adhesive electrodes inserted ...
...bane childcare center, a tuberculosis case alerts ...diagnosed in a childcare worker, who works at the ...Mount Ommaney in west Brisbane. Dr Michael Whitby... Medical Association (AMA) said that children’s (m...
...ast Victoria Sale Hospital's two pediatricians, Jo...ions with three months notice with three months no...xpected for at least six months. This has led to .... Sale obstetrician Dr Refaat Guirguis has said th...
Other Medicine News:Health News:Schizophrenia Complicates With Altered Receptor Activity 2Health News:Schizophrenia Complicates With Altered Receptor Activity 3
(Date:9/3/2008)... that Multaq(R) (dronedarone) decreased the risk o...n or atrial flutter already adequatel... N.J., Sept. 3 /- The resul...ENA study were presented today at,the clinical tri...ology,congress 2008, in Munich, Germany. Previous ...
(Date:9/3/2008)...erations, Updates Zingo Launch Progress and Adlea ... Conference Call Today at 11:30 am ET,...-FirstCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) anno...ations to focus on commercial and late-stage produ...pecialty pharmaceutical pain management,company. T...
(Date:9/3/2008)...uated in Repeat-Dosing Study in Subjects with ALS,... -- Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) ann... trial (SB-509-801) to evaluate its drug, SB-509, ...motor-neuron disease for which there,are limited t...-509, is an injectable formulation of a plasmid,en...
(Date:9/2/2008).../- Forest Laboratories, Inc...day announced results from,two global Phase III st...nhaled anticholinergic for the treatment of patien...D). In both the ACCLAIM/COPD I&II,(AClidinium CLin...te to,Severe COPD Patients) studies, once-daily ac...
Breaking Medicine Technology:Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6Gerber Scientific to Present at 10th Annual Needham Growth Stock Conference 9000 1Gerber Scientific to Present at 10th Annual Needham Growth Stock Conference 9000 2Transcript of Elizabeth Mazzocchi Press Conference 8996 1Transcript of Elizabeth Mazzocchi Press Conference 8996 2Transcript of Elizabeth Mazzocchi Press Conference 8996 3Transcript of Elizabeth Mazzocchi Press Conference 8996 4Transcript of Elizabeth Mazzocchi Press Conference 8996 5Exelixis Announces January 10 Webcast of Presentation at the 26th Annual JPMorgan Healthcare Conference 2415 1Oncolytics Biotech Inc Announces Filing of Phase 1 2 Clinical Trial with REOLYSIN 28R 29 2411 1Oncolytics Biotech Inc Announces Filing of Phase 1 2 Clinical Trial with REOLYSIN 28R 29 2411 2
...Donnelly, MT (ASCP) Contributing Editor , ,Qu...y to meeting the needs of doctors and patients by ...hods. Vendors of these systems can be a valuable r...tocols to help lab managers ensure that analytical...oping suitable QC materials for today,s laboratori...
...l S. Singer, M.D., Ph.D. Contributing Editor Harva...l for heart failure in African American patients h...espond differently to the same medication. This c...edications, and in many cases is due to individual...ics focuses on these issues, valuable new laborato...
Other Medicine Technology:New Quality Control Systems for Every Laboratory Application 2New Quality Control Systems for Every Laboratory Application 3Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 2Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 3
The OCULUS Pachycam is the first compact and portable non-contact pachymeter with built-in keratometer. The OCULUS Pachycam has automatic correction of the IOP (intra ocular pressure) in accordance
...ologies - plus wavefront analysis - in one easy-to...a single device, you can obtain refraction, cornea...vefront analysis. The 3-D Wave allows you to evalu...ve and cataract surgery screenings, evaluate posto...
...re sensor and continues to lead the way. PressureW...measures pressure, temperature and flow. With sign..., it also serves as your primary guidewire, as wel...gh-performance guidewire. , Intracoronary pressu...
...nd and MRI-guided vacuum assisted breast biopsies ...d, FDA-cleared ATEC system for a faster, safer, ea... biopsy. Its compassionate care at its best for th...eful for biopsy and diagnostic excision of breast ...
Medicine Products: